AXGN:NASDAQ
AxoGen, Inc Common Stock
35,24 $
arrow_upward
+1,79%(+0,62) 1D
35,24 $
0,00% (0,00)
bedtimeAfter hours
Closed: 19 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AXGN...
Open
34,86 $
High
35,26 $
Low
34,11 $
Mkt. cap
2,06 մլրդ
Avg. vol.
1,50 մլն
Volume
0,00
52-wk high
52,91 $
52-wk low
16,65 $
EPS
-0,68 $
Beta
1,17
Shares outstanding
58,67 մլն
No. of employees
622
Open
34,86 $
High
35,26 $
Low
34,11 $
Mkt. cap
2,06 մլրդ
Avg. vol.
1,50 մլն
Volume
0,00
52-wk high
52,91 $
52-wk low
16,65 $
EPS
-0,68 $
Beta
1,17
Shares outstanding
58,67 մլն
No. of employees
622
News stories
From web sources and news partners
News-Press NOW
·
30 րոպե առաջ
DataMeds Regains Compliance With NASDAQ Listing Standards
FinancialContent
·
25 րոպե առաջ
Peoples Bancorp (NASDAQ:PEBO) Exceeds Q3 2026 Expectations
MarketWatch
·
4 րոպե առաջ
Why smaller stocks face worse prospects than the S&P 500 in the coming years
Seeking Alpha
·
22 րոպե առաջ
Nasdaq futures slip as Korea tumble weighs on tech (SPX:)
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Tampa, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology Avance to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available nerve allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersAlachua, Ֆլորիդա, Միացյալ Նահանգներ
Sector-
Websiteaxogeninc.com